You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
佰金生命科學(01466.HK)2025財年收入增加至1.36億港元

格隆匯7月25日丨佰金生命科學(01466.HK)公告,2025年財政年度收入增加至1.36億港元。集團於2025年財政年度的虧損爲10萬港元(2024年財政年度:虧損850萬港元),與2024年財政年度的虧損相比,虧損減少99.0%。每股基本虧損爲0.05港仙(2024年財政年度:每股虧損1.15港仙),較2024年財政年度減少95.7%。

集團截至2025年3月31日止年度的虧損大幅減少主要由於收入及毛利增加,主要來自珠寶業務分部;撥回應收貨款及其他應收賬款預期信貸虧損撥備,淨額增加;其他收益,淨額增加;及經抵銷商譽減值虧損及行政開支增加。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account